Asset Details
Do you wish to reserve the book?
Targeting immunometabolism as an anti-inflammatory strategy
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Targeting immunometabolism as an anti-inflammatory strategy
Do you wish to request the book?
Targeting immunometabolism as an anti-inflammatory strategy
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Targeting immunometabolism as an anti-inflammatory strategy
2020
Overview
The growing field of immunometabolism has taught us how metabolic cellular reactions and processes not only provide a means to generate ATP and biosynthetic precursors, but are also a way of controlling immunity and inflammation. Metabolic reprogramming of immune cells is essential for both inflammatory as well as anti-inflammatory responses. Four anti-inflammatory therapies, DMF, Metformin, Methotrexate and Rapamycin all work by affecting metabolism and/or regulating or mimicking endogenous metabolites with anti-inflammatory effects. Evidence is emerging for the targeting of specific metabolic events as a strategy to limit inflammation in different contexts. Here we discuss these recent developments and speculate on the prospect of targeting immunometabolism in the effort to develop novel anti-inflammatory therapeutics. As accumulating evidence for roles of an intricate and elaborate network of metabolic processes, including lipid, amino acid and nucleotide metabolism provides key focal points for developing new therapies, we here turn our attention to glycolysis and the TCA cycle to provide examples of how metabolic intermediates and enzymes can provide potential novel therapeutic targets.
Publisher
Springer Singapore,Nature Publishing Group
Subject
/ 13/106
/ 13/21
/ 38
/ 38/77
/ 38/91
/ Anti-Inflammatory Agents - therapeutic use
/ Autoimmune Diseases - drug therapy
/ Autoimmune Diseases - metabolism
/ Biomedical and Life Sciences
/ Dimethyl Fumarate - pharmacology
/ Dimethyl Fumarate - therapeutic use
/ Humans
/ Immunosuppressive Agents - therapeutic use
/ Lipids
/ Methotrexate - therapeutic use
/ Mimicry
/ Review
